Science Explorer Back to mapMap
Discussion
Researcher · Io Therapeutics (United States) · United States

Rosh Chandraratna

Rosh Chandraratna publishes mostly in Molecular Biology, Immunology and Genetics, on topics such as Retinoids in leukemia and cellular processes, Estrogen and related hormone effects and interferon and immune responses.

OpenAlex
World rank
#5,232,379
of 7,710,434 ranked researchers
Rank in United States
#1,340,244
of 1,627,098
Works
15
Citations
254
Citations per work
16.9
h-index
6
i10-index 5Top 94% in Molecular Biology
Rosh Chandraratna

What does Rosh Chandraratna research?

Rosh Chandraratna's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Immunology and Microbiology (20%), Medicine (15%).

Life Sciences: 9 works · 58.5% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 34.1% of their workMolecular Biology: 4 works · 26.8% of their workGenetics: 1 works · 7.3% of their workImmunology and Microbiology: 3 works · 19.5% of their workImmunology: 3 works · 19.5% of their workNeuroscience: 1 works · 4.9% of their workCellular and Molecular Neuroscience: 1 works · 4.9% of their workEverything else: 4 works · 26.9% of their workHealth Sciences: 2 works · 14.6% of their workMedicine: 2 works · 14.6% of their workOncology: 1 works · 7.3% of their workPulmonary and Respiratory Medicine: 1 works · 7.3% of their workTHEIR WORKRosh Chandraratna15works
Life Sciences58%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology534.1%
    2. Immunology and Microbiology319.5%
    3. Neuroscience14.9%
  2. Everything else426.9%
    1. Medicine214.6%
  1. 1Molecular Biology27% of their works
  2. 2Immunology20% of their works
  3. 3Genetics7% of their works
  4. 4Pulmonary and Respiratory Medicine7% of their works
  5. 5Oncology7% of their works
  6. 6Cellular and Molecular Neuroscience5% of their works

Research topics

Which keywords describe Rosh Chandraratna's research?

The keywords of their largest research topics: Nuclear Receptors, Acute Promyelocytic Leukemia, Retinoic Acid, Inflammation, Transcriptional Regulation, Cancer, Estrogen and Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Nuclear Receptors133 topics
  2. Acute Promyelocytic Leukemia81 topic
  3. Retinoic Acid81 topic
  4. Inflammation63 topics
  5. Transcriptional Regulation52 topics
  6. Cancer42 topics
  7. Estrogen31 topic
  8. Receptor31 topic
  9. Activation21 topic
  10. Adult Stem Cells21 topic
  11. Androgen Receptor21 topic
  12. IL-621 topic
  13. Innate Immunity21 topic
  14. Macrophage21 topic
  15. NR4A221 topic
  16. Neurogenesis21 topic
  17. Nurr121 topic
  18. Prostate Cancer21 topic
  19. STAT321 topic
  20. Viral Infection21 topic

Where does Rosh Chandraratna work?

Rosh Chandraratna's main affiliation in the publication record is Io Therapeutics (United States), United States.

How many publications and citations does Rosh Chandraratna have?

OpenAlex counts 15 works and 254 citations for Rosh Chandraratna, an h-index of 6, ranking #5,232,379 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Rosh Chandraratna. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.